FY22 Drug Recalls Highest in Five Years: FDA Report
The FDA’s fiscal year 2022 report on the State of Pharmaceutical Quality also flagged a spike in inspections, non-compliant products and import alerts.
FY22 Drug Recalls Highest in Five Years: FDA Report Read More »
